SCPX
Scorpius Holdings Inc.

22
Mkt Cap
$739,827.00
Volume
47,841.00
52W High
$0.174
52W Low
$0.0001
PE Ratio
0.00
SCPX Fundamentals
Price
$0.0121
Prev Close
$0.0111
Open
$0.017
50D MA
$0.0025
Beta
-11.82
Avg. Volume
2,142.55
EPS (Annual)
-$13.04
P/B
-0.56
Rev/Employee
$69,366.91
$23.59
Loading...
Loading...

About

Scorpius Holdings, Inc. is a clinical stage company, which engages in the development of immunotherapies designed to activate and expand a patient's T-cell mediated immune system against cancer. The company's T-cell activating platform (TCAP) produces therapies designed to turn immunologically cold tumors to hot and be administered in combination with checkpoint inhibitors and other immuno-modulators to increase clinical effectiveness. Its TCAP product candidates from the company's ImPACT and ComPACT platforms are produced from allogeneic cell lines expressing tumor-specific proteins common among cancers. The company was founded by Jeffrey Alan Wolf on June 10, 2008 and is headquartered in San Antonio, TX.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
90

Frequently Asked Questions

What is Market Cap of Scorpius Holdings Inc.?
What is the 52-week high for Scorpius Holdings Inc.?
What is the 52-week low for Scorpius Holdings Inc.?
What is Scorpius Holdings Inc. stock price today?
What was Scorpius Holdings Inc. stock price yesterday?
What is the Price-to-Book ratio of Scorpius Holdings Inc.?
What is the 50-day moving average of Scorpius Holdings Inc.?
How many employees does Scorpius Holdings Inc. have?

Latest SCPX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.